36 results
6-K
EX-4
AVCRF
Avricore Health Inc.
8 Jun 23
Avricore Health Corporate Updates on Audited Results for 2022
3:18pm
incentives received, retirement costs and initial direct costs. Depreciation is recognized on the right-of-use asset over the lease term. Interest expense
6-K
EX-1
AVCRF
Avricore Health Inc.
13 Oct 22
Current report (foreign)
8:59pm
, adjusted for lease incentives received, retirement costs and initial direct costs. Depreciation is recognized on the right-of-use asset over
6-K
EX-99.2
AVCRF
Avricore Health Inc.
8 Jul 21
Avricore Health Inc.
3:02pm
-of-use asset is recognized at the amount of the lease liability, adjusted for lease incentives received, retirement costs and initial direct costs
6-K
EX-99.2
6qjwr1
17 Jun 21
Avricore Health Announces Filing Update
5:07pm
6-K
EX-99.3
i2w37 mdoyze
17 Jun 21
Avricore Health Announces Filing Update
5:07pm
6-K
EX-99
jffs0sphkw6fk
7 Jun 19
VANC Pharmaceuticals Achieves
12:00am
6-K
EX-99
z9ax0xk
21 Mar 19
Interim Financial Statements
12:00am
20-F/A
9b6gf4d7r42kf7d
19 Jun 18
Annual report (foreign) (amended)
12:00am
20-F/A
xvgbb 951of1b7wox
2 Mar 15
Annual report (foreign) (amended)
12:00am
6-K
EX-99
kv8e6a750 14qyb0
17 Jan 14
Nuva Pharmaceuticals Inc. Form 6-K
12:00am